Kaneka Probiotics: KABP-051 and the future of weight management and psychobiotics
10 Jul 2026 | Kaneka Probiotics
Kaneka Probiotics and AB-Biotics’ latest clinical research on probiotic Lactiplantibacillus plantarum KABP-051 observed modest weight loss alongside improvements mood and energy over 12 weeks, without a diet or exercise plan. Jordi Riera, chief business officer at Kaneka Probiotics, reveals further study details while explaining what a microbiome-based approach means for the future of psychobiotics.
Upcoming webinars

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Aging Is Inevitable. Longevity Is Negotiable
Sabinsa

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients















